Ignite Creation Date:
2025-12-24 @ 3:24 PM
Ignite Modification Date:
2026-03-16 @ 6:44 AM
Study NCT ID:
NCT06601192
Status:
COMPLETED
Last Update Posted:
2025-07-28
First Post:
2024-08-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy Adults
Sponsor:
Enanta Pharmaceuticals, Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EDP 938-008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None